On CNBC's "Mad Money Lightning Round," Jim Cramer said he isn't happy with the way Inseego Corp INSG acts. He is beginning to believe it deserves to be trading 45% lower.
Biohaven Pharmaceutical Holding Co Ltd BHVN is instrumental, said Cramer. He likes its drug Nurtec.
Cramer is not a buyer of Service Corporation International SCI. He said there are ways to make COVID-19 less life-threatening than the last year.
Cramer is astonished at how much Vertex Pharmaceuticals VRTX has fallen given its cystic fibrosis franchise. He wouldn't sell it at its current price.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.